Home > Insider Trading > Filing (0001104659-16-104261)

Filing Details

Accession Number:: 0001104659-16-104261
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-10 17:08:35
Reporting Period:: 2016-03-08

Filing Date:: 2016-03-10
Accepted Time:: 2016-03-10 17:08:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1081714	R Henry Kravis	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1081715	R George Roberts	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1404912	Kkr & Co. L.p.	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1472694	Kkr Management Llc	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1472695	Ltd Group Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1472696	L.p. Holdings Group Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1472697	Ltd Gp Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No
1472698	L.p. Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p., 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-03-08	4,829,981	$42.26	35,103,676	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes

Footnotes

This amount represents the secondary price per share of common stock, par value $0.01 per share, of PRA Health Sciences, Inc. received by KKR PRA Investors L.P. in an underwritten secondary block trade.
Securities are held by KKR PRA Investors L.P. KKR PRA Investors GP II LLC is the sole general partner of KKR PRA Investors L.P. KKR PRA Investors GP LLC is the sole member of KKR PRA Investors GP II LLC. KKR North America Fund XI L.P. is the sole member of KKR PRA Investors GP LLC. KKR Associates North America XI L.P. is the general partner of KKR North America Fund XI L.P. KKR North America XI Limited is the general partner of KKR Associates North America XI L.P. KKR Fund Holdings L.P. is the sole shareholder of KKR North America XI Limited. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P.
KKR Group Holdings L.P. is the sole shareholder of KKR Fund Holdings GP Limited and a general partner of KKR Fund Holdings L.P. KKR Group Limited is the general partner of KKR Group Holdings L.P. KKR & Co. L.P. is the sole shareholder of KKR Group Limited. KKR Management LLC is the general partner of KKR & Co. L.P. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC.
Each of the Reporting Persons (other than KKR PRA Investors L.P.), disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than KKR PRA Investors L.P.) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.